Welcome to IFPMA’s Global Health Matters blog. We are launching this forum to foster exchange and dialog on health topics that matter to all of us. As you know, the issues and challenges that organizations and individuals in the global health community face daily are plentiful, complex, and ever-changing. We believe a good way for...
Read moreIn this first Global Health Matters entry, I want to address an important and much-discussed topic on the global health agenda: WHO engagement with non-state actors. In the WHO context, “engagement” can have a variety of meanings and can spur different reactions. It may range from simple dialogue to cooperation, collaboration, formal partnership or even...
Read morePartnership is a novel cross-sector collaboration, responding to the United Nations call to tackle non-communicable diseases (NCDs) Initiative goes beyond awareness-raising campaigns by prompting behavioral changes Strategically combining expertise from pharmaceutical and humanitarian sectors, this initiative is expected to reach three million people The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the...
Read moreCopyright:PATH This three-minute video examines the growing challenges of maintaining reliable vaccine supply and logistics systems and offers potential solutions toward achieving optimized, efficient systems that reach people with the vaccines they need.
Read moreCopyright: PATH This three-minute video examines the growing challenges of maintaining reliable vaccine supply and logistics systems and offers potential solutions toward achieving optimized, efficient systems that reach people with the vaccines they need.
Read moreDavid Taylor, Professor of Pharmaceutical and Public Health Policy, UCL School of Pharmacy Geneva Pharma Forum: The Threat of False Friends Fake Medicines – Imminent Risks to Global Health to Global Health
Read moreGeneva Pharma Forum: Putting NCDs into Focus
Read moreJamil Chade, Journalist Mario Ottiglio, IFPMA David Taylor, Professor of Pharmaceutical and Public Health Policy, UCL School of Pharmacy Robert Johnstone, Board Member, IAPO Luc Besancon, Acting General Secretary for Professional, Scientific and External affairs, International Pharmaceutical Federation Martin Bernhardt, Vice President International Institutions, Sanofi
Read moreGeneva Pharma Forum: The Threat of False Friends Opening remarks: Jamil Chade Fake Medicines – Imminent Risks to Global Health to Global Health
Read moreThe Novartis experience in natural product research — complexity, challenges and successful collaborations. Frank Petersen — Head of Natural Products Unit, Novartis Institutes for BioMedical Research.
Read moreThe experience of BIOTEC in natural product research and the collaboration with Novartis Bubpha Techapattaraporn — Head of Biotechnology Research section (BIOTEC, Thailand) Genetic Engineering and Biotechnology, Thailand
Read moreThe critical role of universities in the innovation eco-system Mark Crowell — Executive Director, UVa Innovation (University of Virginia)
Read more